IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Molecular Cancer

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

28.85

h-Index

2022-2023

 171

Rank

2022-2023

 96

SJR

2022-2023

 8.703

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Molecular Cancer
Abbreviation Mol. Cancer
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1)
h-index 171
Overall Rank/Ranking 96
SCImago Journal Rank (SJR) 8.703
Impact Score 28.85
Publisher BioMed Central Ltd.
Country United Kingdom
ISSN 14764598
Best Quartile Q1
Coverage History 2002-2022




Aim and Scope


Molecular Cancer is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer.


About Molecular Cancer


Molecular Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1). It is published by BioMed Central Ltd.. The overall rank of Molecular Cancer is 96. According to SCImago Journal Rank (SJR), this journal is ranked 8.703. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 171. The best quartile for this journal is Q1.

The ISSN of Molecular Cancer journal is 14764598. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Cancer is cited by a total of 17050 articles during the last 3 years (Preceding 2022).


Molecular Cancer Impact IF 2022-2023


The Impact IF 2022 of Molecular Cancer is 28.85, which is computed in 2023 as per its definition. Molecular Cancer IF is decreased by a factor of 6.58 and approximate percentage change is -18.57% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Molecular Cancer Impact IF 2023 Prediction


Impact IF 2022 of Molecular Cancer is 28.85. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Molecular Cancer. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 28.85
2021 35.43
2020 25.00
2019 15.04
2018 10.82
2017 7.98
2016 6.52
2015 6.35
2014 4.80

Molecular Cancer h-index


  Table Setting

Molecular Cancer has an h-index of 171. It means 171 articles of this journal have more than 171 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Molecular Cancer ISSN


The ISSN of Molecular Cancer is 14764598. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Molecular Cancer Rank and SCImago Journal Rank (SJR)


The overall rank of Molecular Cancer is 96. According to SCImago Journal Rank (SJR), this journal is ranked 8.703. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Molecular Cancer by Year


Year SJR
2023/2024 Coming Soon
2022 8.703
2021 6.896
2020 7.274
2019 4.581
2018 3.274
2017 2.778
2016 2.439
2015 2.406
2014 2.453

Ranking of Molecular Cancer by Year


Year Ranking
2023/2024 Coming Soon
2022 96
2021 147
2020 151
2019 313
2018 565
2017 751
2016 975
2015 1014
2014 955

Molecular Cancer Publisher


Table Setting

Molecular Cancer is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2002-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Molecular Cancer is Mol. Cancer. This abbreviation ('Mol. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Molecular Cancer


If your research field is/are related to Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Molecular Cancer?

Molecular Cancer latest impact IF is 28.85. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 35.43 (2021) and 4.80 (2014), respectively, in the last 9 years. Moreover, its average IS is 15.64 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Molecular Cancer?

The Molecular Cancer has an SJR (SCImago Journal Rank) of 8.703, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 8.703 in 2022 and the lowest being 2.406 in 2015. Furthermore, the average SJR of the Molecular Cancer over the previous 9-year period stands at 15.64.


What's the latest h-index of the Molecular Cancer?

The latest h-index of the Molecular Cancer is 171.


Who's the publisher of the Molecular Cancer?

The Molecular Cancer is published by the BioMed Central Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Molecular Cancer?

The Molecular Cancer is currently ranked 96 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 96 in 2022 and its lowest position of 1014 in 2015.


What's the abbreviation or short name for the Molecular Cancer?

The standard ISO4 abbreviation for the Molecular Cancer is Mol. Cancer.


Is the "Molecular Cancer" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Molecular Cancer is classified as a journal that the BioMed Central Ltd. publishes.


What's the scope or major areas of the Molecular Cancer?

The Molecular Cancer encompasses the following areas:

  • Cancer Research
  • Molecular Medicine
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Molecular Cancer?

The Molecular Cancer is assigned the following International Standard Serial Numbers (ISSN): 14764598.


What's the best quartile of the Molecular Cancer?

The best quartile for the Molecular Cancer is Q1 (2022).


What's the coverage history of the Molecular Cancer?

The Molecular Cancer coverage history can be summarized as follows: 2002-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 13414 Vilnius Gediminas Technical University 21 2.47
Journal of Supply Chain Management journal 378 Wiley-Blackwell 104 12.58
Entrepreneurship Theory and Practice journal 338 Wiley-Blackwell 185 12.75
Materials Research journal 14791 Universidade Federal de Sao Carlos 65 1.62
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
International Journal of Applied Linguistics journal 7321 Wiley-Blackwell Publishing Ltd 51 2.00
World Englishes journal 4960 Wiley-Blackwell 60 1.97
Journal, Indian Academy of Clinical Medicine journal 24608 Indian Academy of Clinical Medicine 16 0.06
International Journal of Research and Method in Education journal 5180 Taylor and Francis Ltd. 34 2.49
Sex Education journal 5168 Routledge 41 2.82

Check complete list




Year wise Impact Score (IS) of Molecular Cancer

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 28.85
2021 35.43
2020 25.00
2019 15.04
2018 10.82
2017 7.98
2016 6.52
2015 6.35
2014 4.80



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All